This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monsanto's Still Planting for the Future

NEW YORK ( TheStreet) -- There's never a dull moment in the world of Monsanto (MON - Get Report). When the company is not being publicly crucified for its genetically modified seeds, controversy spreads about the company's ethics and what many believe to be Monsanto's unfair pricing tactics.

These (among other things) have soured Monsanto's relationship not only with the farmers that rely on its seeds, but also with consumers who buy the produce.

However, even with all of the public bickering, investors who have planted their faith in Monsanto have not gone hungry. That the stock has posted gains of more than 17% on the year is a testament not only to strong management team, but also the extent to which Monsanto has differentiate its products from rivals DuPont (DD) and Syngenta (SYT). I don't believe investors will get a better chance to get in on this dominant agriculture company than on this recent pullback.

As of this writing, the stock is down more than 5% from a high of around $109 per share in May. The stock has taken a slight hit because not only did Monsanto report a worse-than-expected loss for its fiscal fourth quarter on Wednesday, but management also provided guidance that was below Street expectations. Investors have -- understandably -- become anxious. But I don't believe it's time to panic.

For instance, even with the 1.5% decline in overall revenue, sales of cotton seeds more than doubled to $65 million. What's more, that the Agriculture business continue to pose year-over-year double-digit gains (up 13.6%), management has plenty of time to shore up weakness in areas like soybeans. While it's true the company did report a higher operating loss, it's worth noting here that the fourth quarter has always known to be a seasonally weak period for the company.

To that end, those who are now proclaiming that Monsanto is "getting what it deserves" have to do a better job of explaining that actually means. Clearly, there are many who will disagree with me on this, but the way I see it Monsanto has always had a strong business.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
MON $118.46 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs